Proniras Corporation
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder (NCT06538558) | Proniras Corporation | 2024-10-16 |
Track Proniras Corporation automatically
Every clearance here is in the API, with alerts when new ones post.